• 1. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 2. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Comprehensive Overview of Spiro[1-azabicyclo[2.2.2]octane-3,2'-pyrrolidin]-3'-amine, 1'-methyl- (CAS No. 2137488-83-4)

Spiro[1-azabicyclo[2.2.2]octane-3,2'-pyrrolidin]-3'-amine, 1'-methyl- (CAS No. 2137488-83-4) is a structurally unique compound that has garnered significant attention in pharmaceutical and chemical research due to its spirocyclic framework and potential biological activities. This molecule features a 1-azabicyclo[2.2.2]octane core fused with a pyrrolidine ring, creating a rigid three-dimensional architecture. Such spirocyclic systems are increasingly explored for their ability to modulate protein-protein interactions and enhance drug-like properties, making them a hotspot in medicinal chemistry and drug discovery.

The compound's CAS number 2137488-83-4 serves as a critical identifier for researchers seeking precise chemical data. Its 1'-methyl-3'-amine substitution pattern further enhances its versatility, enabling derivatization for targeted applications. Recent studies highlight the growing interest in spirocyclic amines as scaffolds for central nervous system (CNS) therapeutics, with potential implications for neurodegenerative diseases and psychiatric disorders. This aligns with trending searches on "spirocyclic compounds in neuroscience" and "novel amine-based drug candidates," reflecting the scientific community's focus on innovative molecular designs.

From a synthetic perspective, Spiro[1-azabicyclo[2.2.2]octane-3,2'-pyrrolidin]-3'-amine, 1'-methyl- exemplifies advancements in stereoselective synthesis. Its preparation often involves key steps like aza-Diels-Alder reactions or ring-closing metathesis, topics frequently queried in academic databases. The compound's chiral centers and bridged bicyclic system also make it a valuable subject for computational chemistry studies, particularly in molecular docking simulations—a trending topic in AI-driven drug design.

In the context of green chemistry, researchers are investigating sustainable routes to synthesize this spirocyclic amine, addressing popular queries like "eco-friendly heterocyclic synthesis." Its potential as a building block for high-value pharmaceuticals further underscores its relevance. Notably, the 1-azabicyclo[2.2.2]octane moiety shares structural similarities with fragments found in FDA-approved drugs, sparking interest in its bioisosteric potential—a frequently searched term in patent literature.

Analytical characterization of CAS No. 2137488-83-4 typically involves advanced techniques like NMR spectroscopy and high-resolution mass spectrometry, aligning with laboratory professionals' search trends. The compound's logP and pKa values (often queried in property databases) are crucial for predicting its ADME profiles—a critical consideration in preclinical development. This bridges the gap between synthetic chemistry and pharmacokinetic optimization, two areas dominating current pharmaceutical discourse.

Emerging applications of this spirocyclic amine include its exploration as a ligand in catalysis and as a template for metal-organic frameworks (MOFs)—topics gaining traction in materials science forums. Its hydrogen-bonding capacity and conformational rigidity make it particularly attractive for these purposes. These multidisciplinary applications respond to increasing searches for "multifunctional spiro compounds" and "hybrid organic-inorganic materials."

In summary, Spiro[1-azabicyclo[2.2.2]octane-3,2'-pyrrolidin]-3'-amine, 1'-methyl- represents a compelling case study in modern chemical research, intersecting synthetic innovation, computational modeling, and therapeutic potential. Its CAS registry number 2137488-83-4 will continue to appear in cutting-edge publications as researchers unlock further applications of this structurally sophisticated amine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)